Smith & Nephew (SNN) Stock Forecast & Price Target

SNN Forecast - Frequently Asked Questions

Should I buy or sell Smith & Nephew stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Smith & Nephew in the last year. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" SNN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SNN, but not buy additional shares or sell existing shares.

Does Smith & Nephew's stock price have much downside?

According to analysts, Smith & Nephew's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Has Smith & Nephew been downgraded by Wall Street analysts recently?

Over the previous 90 days, Smith & Nephew's stock had 2 downgrades by analysts.

What analysts cover Smith & Nephew?

Smith & Nephew has been rated by research analysts at Berenberg Bank, and Deutsche Bank Aktiengesellschaft in the past 90 days.

Do Wall Street analysts like Smith & Nephew more than its competitors?

Analysts like Smith & Nephew less than other "medical" companies. The consensus rating for Smith & Nephew is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how SNN compares to other companies.